Effectiveness of the 2025–2026 trivalent influenza vaccine against laboratory-confirmed influenza among older adults in Eastern China: A test-negative case–control study

Yugang Shen, Ling Zhang, Qianmei Liu, Xiaoyang Ou, Jiawen Qian, Libo Ren

Open source

DOI
10.1080/21645515.2026.2759393
Published
2026-11-08
Container
Human Vaccines & Immunotherapeutics
Publisher
Informa UK Limited
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1080/21645515.2026.2759393,
  title = {Effectiveness of the 2025–2026 trivalent influenza vaccine against laboratory-confirmed influenza among older adults in Eastern China: A test-negative case–control study},
  author = {Yugang Shen and Ling Zhang and Qianmei Liu and Xiaoyang Ou and Jiawen Qian and Libo Ren},
  year = {2026},
  journal = {Human Vaccines \& Immunotherapeutics},
  doi = {10.1080/21645515.2026.2759393},
  url = {https://doi.org/10.1080/21645515.2026.2759393}
}

RIS

TY  - JOUR
TI  - Effectiveness of the 2025–2026 trivalent influenza vaccine against laboratory-confirmed influenza among older adults in Eastern China: A test-negative case–control study
AU  - Yugang Shen
AU  - Ling Zhang
AU  - Qianmei Liu
AU  - Xiaoyang Ou
AU  - Jiawen Qian
AU  - Libo Ren
PY  - 2026
JO  - Human Vaccines & Immunotherapeutics
DO  - 10.1080/21645515.2026.2759393
UR  - https://doi.org/10.1080/21645515.2026.2759393
ER  - 

APA

Shen, Y., Zhang, L., Liu, Q., Ou, X., Qian, J., & Ren, L. (2026). Effectiveness of the 2025–2026 trivalent influenza vaccine against laboratory-confirmed influenza among older adults in Eastern China: A test-negative case–control study. Human Vaccines & Immunotherapeutics. https://doi.org/10.1080/21645515.2026.2759393

Source records